FAIL (the browser should render some flash content, not this).

Major events

Banner
Banner
nickel_klima_eng

nickel_klima_eng

  Design, realization and maintenance of cleanroom systems cleanroom walls, ceilings, doors, airshowers HVAC Systems controls systems (DDC) cleanroom floors cleanroom lighting monitoring systems technology (gas pipes) set and test runs and implementation validation and IQ, OQ documentation The main objective of our company is to provide complete and operating cleanrooms for our clients including the necessary validation and IQ, OQ documentation commencing with ....

airmax_eng

airmax_eng

    Airmax Cargo Budapest Ltd. provides air, ocean, and land based forwarding services as well as warehousing logistics solutions since 16 years for its continuously growing national and international customer pool.  Our GTP trained expert staff has great experience in dealing with sensitive goods requiring special care – like perishable or dangerous drugs and pharmaceutical products, biotechnological samples, research material, valuable goods requiring protective....

Events

Events

 

Pharmahungary Group

Pharmahungary Group

 Pharmahungary Group Innovative preclinical & clinical pharmacology contract research: from in vitro to in vivo efficacy and proof-of-concept studies in cardiovascular and metabolic diseases. Mission of Pharmahungary providing wide range of innovative and cost-effective preclinical pharmacology R&D services focusing on cardiovascular (infarction, heart failure, stroke, sepsis, arrhythmias, etc) and metabolic diseases (diabetes, dyslipidemia, atherosclero....

ENVIROINVEST Inc.

ENVIROINVEST Inc.

The ENVIROINVEST Incorporated for Environmental Protection and Biotechnology (ENVIROINVEST Inc.) continues the activities of its former companies (as the successor of  the Enviroinvest Ltd., the Enviroinvest-Waste Ltd., and the Ekofutur Ltd) from 01 September 2010. The company is seated in 2 Kertváros Street, Pécs, H-7632 HUNGARY. The main objective of the company is to protect the natural and built environment, to save their values, to reduce pollution and eliminate environmental d....

Assign

Assign

Assign is a midsize European CRO, offering full service in clinical research from phase I to IV. Our expertise includes the design of clinical development plans, study synopsis and protocol writing, feasibility studies, project management, monitoring, quality and data management, biostatistics and study drug management incl. QP release. We offer the following services: -     Clinical Research -     Data Management, Biostatistics, Medical ....

HBA Company Profiles

HBA Company Profiles

                            

DSS Consulting Ltd.

DSS Consulting Ltd.

DSS Consulting Ltd. was founded in 1998. Our company is engaged in informatics developments. Currently we employ 60 software designers, developers, programming mathematicians, informatics experts and project managers for the development of highly innovative tailor-made solutions and applications. Main fields of activities: - Data warehouse development, data mining, system integration, - Tailor-made algorithm- software- and application development, intelligent business solutions, decision supp....

UD-GenoMed

UD-GenoMed

UD-GenoMed – your genomic service provider! Our well-prepared, time-guaranteed, high quality functional genomic services by experienced employees are served for research institutions, big pharmas and biotech companies. Do you suffer from investing money to optimize the way of drug development without any significant result? Do you not have in-house capacity to build up your own method? Our company provides adherence, time-guaranteed, trustful functional genomic services for big pharmaceutica....

EGIS PLC

EGIS PLC

EGIS PLC is one of the leading pharmaceutical companies of Hungary and the Central Eastern European region. Our activities extend to nearly every field of pharmaceutical production: from generic and original research and development, through the production of active ingredients and finished products to sales and marketing. We mainly focus on drugs acting on the cardiovascular, the central nervous and respiratory systems. As one of the most innovative companies in the Central Eastern European reg....

EU promotes innovation to boost economic growth

EU promotes innovation to boost economic growth

Innovation is vital for growth, economic re-balancing and recovery, Maire Geoghegan-Quinn, European Commissioner for Research, Innovation and Science, said on Monday in London.

Three days after the European Council summit gathered European Union (EU) leaders to discuss innovation and energy issues, Geoghegan-Quinn paid a visit to the British Science Royal Society to promote the economic and social benefits of innovation.

"Innovation is vital for growth," she said in a statement released on the EU website. According to the commissioner, innovation is one of the keys to rebalancing EU economies and ensuring long-term economic recovery.

The commissioner encouraged member states to maintain investment in research and development (R&D) and innovation, as reaching the EU target of investing 3 percent of gross domestic product (GDP) in R&D could create around 4 million jobs and increase annual GDP by 700 billion euros ($954 billion) by 2025.

Geoghegan-Quinn underlined the need to harmonize innovation and research funding through the adoption of the Common Strategic Framework that could bring together many EU funding instruments.

"European Research funding is currently spread across too many small programs and different instruments, sometimes with insufficient scale and scope to make real breakthroughs in a visible way," she said.

The European Commission is expected to present its Green Paper on future EU funding for research and innovation on Wednesday, with proposals to cut red tape for scientists and facilitate funding to be discussed, among others.

The commissioner also called on member states to work on completing the European Research Area by 2014, with the view to enhancing cross border cooperation in research and innovation.

She also highlighted the importance of launching European Innovation Partnerships, such as the already agreed pilot partnership on active and healthy ageing, which aims to increase the average healthy lifespan in Europe by two years by 2020.

By bringing together the main stakeholders in a particular field, innovation partnerships are expected to help speed up the development and deployment of the technologies needed to meet the challenges the EU is facing.

"I am convinced that science, research and innovation have a bright future in Europe," she said. "I am convinced that they will do much for Europe."